Analisis Efektivitas Biaya Penggunaan Obat Antihipertensi pada Pasien Penyakit Gagal Jantung Kongestif di Rumah Sakit Pendidikan Prof. Dr. Chairuddin P. Lubis Universitas Sumatera Utara

Abstract

Background: Congestive heart failure in indonesia is the second leading cause of death after stroke. The increase in healthcare costs caused by medication usage rises by approximately 10% each year. One approach in the field of pharmacoeconomics used to evaluate and select the most cost effective therapy from various options is Cost effectiveness Analysis. Objective: The purpose of this study is to evaluate various antihypertensive therapy models used in patients with Congestive Heart Failure (CHF) at Prof. Dr. Chairuddin P. Lubis Educational Hospital, Universitas Sumatera Utara, the research aims to determine the most cost effective antihypertensive therapy model at the hospital. Methods: The data collection was conducted retrospectively based on the medical records of hospitalized Congestive Heart Failure (CHF) patients. From this data collection, a sample of 85 patients who met the established inclusion criteria was obtained. Result: Based on the research findings, patients were grouped according to therapy models, followed by an analysis to determine the most cost effective therapy within each therapy group. The majority of patients (58.83%) were male, and the most prevalent age group was >60 years (60%). According to the study, the combination therapy of Beta Blocker (BB) + Diuretic proved to be the most cost effective with the lowest CER value of Rp9.080. Conclusion: The conclusion of this study is that there are 11 antihypertensive therapy models used at Prof. Dr. Chairuddin P. Lubis Educational Hospital, Universitas Sumatera Utara. Among these 11 models, the combination therapy of Beta Blocker (BB) + Diuretic is the most cost effective antihypertensive group.